Skip to main content
. 2020 Feb 10;26:e918207-1–e918207-8. doi: 10.12659/MSM.918207

Figure 5.

Figure 5

The effects of ginsenoside Rg1 (Rg1) on TSC2 expression in CD34+CD38− leukemia stem cells (LSCs) derived from KG1α human acute myeloid (AML) leukemia cells. (A) The evaluation for mRNA expression of TSC2 following treatment with ginsenoside Rg1 (Rg1) using the quantitative reverse transcription-polymerase chain reaction (qRT-PCR). (B) The evaluation of tuberous sclerosis complex 2 (TSC2) protein expression following treatment with Rg1 using Western blot. (C) Statistical analysis of TSC2 expression. * p<0.05 vs. the control group.